TRYBE®: an Fc-free antibody format with three monovalent targeting arms engineered for long in vivo half-life
ABSTRACTTrYbe® is an Fc-free therapeutic antibody format, capable of engaging up to three targets simultaneously, with long in vivo half-life conferred by albumin binding. This format is shown by small-angle X-ray scattering to be conformationally flexible with favorable 'reach' properties...
Saved in:
Main Authors: | Emma Davé (Author), Oliver Durrant (Author), Neha Dhami (Author), Joanne Compson (Author), Janice Broadbridge (Author), Sophie Archer (Author), Asher Maroof (Author), Kevin Whale (Author), Karelle Menochet (Author), Pierre Bonnaillie (Author), Emily Barry (Author), Gavin Wild (Author), Claude Peerboom (Author), Pallavi Bhatta (Author), Mark Ellis (Author), Matthew Hinchliffe (Author), David P. Humphreys (Author), Sam P. Heywood (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2023-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Interactions of the anti-FcRn monoclonal antibody, rozanolixizumab, with Fcγ receptors and functional impact on immune cells in vitro
by: Omar S. Qureshi, et al.
Published: (2024) -
Microtitration of Rubella Virus in Monovalent Vaccinal Products
by: F Esna-Ashari, et al.
Published: (2011) -
Microtitration of Rubella Virus in Monovalent Vaccinal Products
by: F Esna-Ashari, et al.
Published: (2011) -
Antibody Fc engineering for enhanced neonatal Fc receptor binding and prolonged circulation half-life
by: Brian C. Mackness, et al.
Published: (2019) -
EVALUATION OF REACTOGENICITY, SAFETY AND IMMUNOGENICITY OF INACTIVATED MONOVALENT VACCINE IN CHILDREN
by: A.N. Mironov, et al.
Published: (2010)